- Thu Aug 01, 2024 8:13 am
#74034
BMA have serious reservations about the Cass review, particularly the methodology. Recommend not implementing a puberty blocker ban, note that trans healthcare in the U.K. is poor, and are pressing ahead with an even more thorough review. Be interesting to see what Streeting’s reaction is:
https://www.pulsetoday.co.uk/news/clini ... nt-advice/
https://www.pulsetoday.co.uk/news/clini ... nt-advice/
Samanfur liked this